The neglected diseases are a group of tropical infections which are especially endemic in low-income populations in developing regions of Africa, Asia, and the Americas. Different groups define the set of diseases differently. Together, they cause an estimated 500,000 to 1 million deaths annually and cause a global disease burden higher than that of HIV-AIDS.
Some of these diseases have known preventive measures or acute medical treatments which are available in the developed world but which are not universally available in poorer areas. In some cases, the treatments are relatively inexpensive. For example, the treatment for schistosomiasis is USD $0.20 per child per year.
These diseases are contrasted with the big three diseases (HIV/AIDS, tuberculosis and malaria), which generally receive greater funding and research funding. The neglected diseases can also make HIV/AIDS and tuberculosis more deadly..
However, some pharmaceutical companies have committed to donating all the drug therapies required and mass drug administration have successfully accomplished in several countries.
List of Neglected Diseases
Neglected tropical diseases include in order of decreasing prevalence: roundworm (ascariasis), whipworm (trichuriasis), hookworm (necatoriasis, ancylostomiasis), snail fever (schistosomiasis), elephantiasis (lymphatic filariasis), trachoma, Kala-azar black fever (leishmaniasis), Chagas disease (American trypanosomiasis), leprosy, African sleeping sickness (African trypanosomiasis), Guinea worm (dracunculiasis), and buruli ulcer.
- Kala-azar (visceral leishmaniasis, a severe form of leishmaniasis) - Treatments exist, most of them costly and/or toxic. Resistance to pentavalent antimonials is spreading in parts of India. Disease is fatal if untreated. Vaccines are under development as of 2006. Infection is spread by the bite of sandflies.
- African Sleeping Sickness (African trypanosomiasis) - Disease was nearly eradicated in the 20th century, but relaxation in control methods has led to resurgence. Treatments exist, but have not changed much since colonial times due to lack of further research. The current forms of treatment are ineffective, highly toxic and resistance is spreading. This disease is always fatal if untreated but the outcome is often the same with the existing treatment. Infection is spread by the bite of the tsetse fly.
- Chagas disease (American trypanosomiasis) - No vaccine exists for Chagas disease. Treatment for early infection exists but is uneconomical and not authorized as such, current drugs have severe side effects. Chagas disease does not kill victims rapidly, instead causing years of debilitating chronic symptoms. Bites from South American assassin bugs allow the disease to spread.
Worm (helminth) parasites
- Schistosomiasis - Inexpensive praziquantel can treat this disease, but cannot prevent reinfection. Other treatments are harder to obtain in the developing world. Multiple vaccines are under development. ''Schistosoma'' species have a complex life cycle that alternates between humans and freshwater snails; infection occurs upon contact with contaminated water. This disease is unique in that damage is not caused by the worms themselves, but rather by the large volume of eggs that the worms produce.
- Lymphatic Filariasis (causes elephantiasis) - Effective antihelminthic treatments have been widely used in a cost-effective manner
- Onchocerciasis (river blindness) - Antihelminthic treatment exists, prevention may also involve insect control
- Drancunculiasis (guinea worm) - Eradication goal is 2009, as of 2007
- Ascariasis (roundworm) - Antihelminthic treatments exist, prevention involves food and sewage sanitation
- Trichuriasis (whipworm) - Antihelminthic treatments exist, prevention involves food and sewage sanitation
- Hookworm - Antihelminthic treatments exist, prevention involves food and sewage sanitation
- Strongyloidiasis - Antihelminthic treatments exist, prevention involves sewage sanitation and prevention of malnutrition
- Leprosy - Antibiotic treatments exist which can clear the infection; BCG vaccine has some preventative effect.
- Buruli ulcer - Surgical and antibiotic interventions are recommended
- Trachoma - Antibiotic treatments exist, prevention involves interpersonal hygiene
- Cholera - Cholera is caused by ''Vibrio cholerae'' bacteria living in contaminated drinking water. The disease presents with severe, watery diarrhea after a short incubation period lasting from zero to five days. Cholera is especially dangerous because it can kill patients in less than 24 hours from rapid dehydration. Antibacterial treatments can cure the disease, but most effective is isotonic fluid replacement therapy, which reduces deaths to 1% of cases. Cholera can be prevented with limited efficacy by two oral vaccines, but access to clean drinking water provides a guarantee of prevention.
- Yellow fever - A vaccine exists for Yellow fever. Yellow fever, like some other neglected diseases, is caused by a flavivirus
- Dengue fever - Dengue fever is also caused by a flavivirus, and is spread by the bite of the ''A. Aegypti'' mosquito. Dengue fever is not usually fatal, but infection with one of four serotypes can increase later susceptibility to other serotypes, resulting in the highly dangerous Dengue hemorrhagic fever (DHF). No treatment for either type of disease exists beyond palliative care.
- Japanese Encephalitis - Japanese encephalitis is also caused by a flavivirus. The disease is spread by ''Culex tritaeniorhynchus'' mosquitoes.
Incentives for Treating Neglected Diseases
The Priority Review Voucher is an incentive for companies to invest in new drugs and vaccines for neglected tropical diseases. A provision of the Food and Drug Administration Amendments Act (HR 3580) awards a transferable “priority review voucher” to any company that obtains approval for a treatment for a neglected tropical disease. This provision adds to the market based incentives available for the development of new medicines for Neglected Diseases.
The prize was proposed by Duke University faculty Henry Grabowski, Jeffrey Moe, and David Ridley in their 2006 ''Health Affairs'' paper: "Developing Drugs for Developing Countries." In 2007 United States Senators Sam Brownback (R-KS) and Sherrod Brown (D-OH) sponsored an amendment to the Food and Drug Administration Amendments Act of 2007. President George W. Bush signed the bill in September 2007.
This article is licensed under the Creative Commons Attribution-ShareAlike License.
It uses material from the Wikipedia article on
All material adapted used from Wikipedia is available under the terms of the
Creative Commons Attribution-ShareAlike License.
Wikipedia® itself is a registered trademark of the Wikimedia Foundation, Inc.